Progressive Renal Dysfunction in Autosomal-dominant Alport Syndrome Co-occurring with C1q Nephropathy
A 47-year-old man with nephrotic syndrome and stage 4 chronic kidney disease was diagnosed with C1q nephropathy presenting with focal segmental glomerulosclerosis (FSGS) on a renal biopsy. A genetic analysis performed because of a family history of microscopic hematuria and lamellar glomerular basement membranes identified a heterozygous COL4A4 variant, leading to a genetic diagnosis of autosomal-dominant Alport syndrome (ADAS). Despite immunosuppressive therapy, the patient progressed to end-stage kidney disease much earlier than in previously reported cases of C1q nephropathy. This case suggests that the synergistic effects of C1q nephropathy-induced podocyte damage and abnormal glomerular basement membrane due to ADAS may promote rapid progression of FSGS.
Authors
- Eisei Sohara (ORCID: https://orcid.org/0000-0003-1668-8308)
- Michiko Suzuki (ORCID: https://orcid.org/0000-0002-2264-7230)
- Takayasu Mori (ORCID: https://orcid.org/0000-0002-9308-7787)
- Fumika Taki
- Nozomi Kadota
- Kasumi Konishi
- Takuya Fujimaru (ORCID: https://orcid.org/0000-0002-6825-3456)
- Motoko Chiga
- Michio Nagata (ORCID: https://orcid.org/0000-0002-7360-5524)
- Masaaki Nakayama (ORCID: https://orcid.org/0000-0002-7686-8899)
- Yugo Ito
- Shinichi Uchida (ORCID: https://orcid.org/0000-0003-1491-6071)
- Masahiko Nagahama
Institutions
- St. Luke's International Hospital (JP)
- Mie Chuo Medical Center (JP)
Publication Details
- Journal
- Internal Medicine
- Published
- 2025-06-18
- DOI
- https://doi.org/10.2169/internalmedicine.5196-24
- Primary Topic
- Cell Adhesion Molecules Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00